TNNI3 and heart failure: There were no significant differences in age, gender, PCIS, hypotension, shock, use of vasoactive drugs, heart failure, respiratory failure, MODS, and mortality rate between the cTnI- and CK-MB-elevated groups (P > 0.05) (Table 3).